Giants of Cancer Care Awards Program Advisory Panel Grows By Leaps and Bounds

Article

OncLive brings total of 29 esteemed oncologists to awards panel for insight.

The Giants of Cancer Care program, presented by OncLive, announced today that 10 new members have joined their Advisory Panel, the judiciary body for the premier awards program. These additions bring the total number of advisory panel members to 29, and highlights the continued growth of the program in 2014.

The Giants of Cancer Care initiative recognizes and celebrates individuals who have achieved landmark success within the field of oncology. The Advisory Panel is an exclusive board of oncologists, educators, clinicians and researchers who have dedicated their valuable time to the program, providing guidance to OncLive as it further develops the program and, most importantly, selects the oncologists who will be named Giants.

The Advisory Panel’s insights are crucial for continued success, and the new members will bring their exemplary experience and tenure to the program. The complete advisory panel list is as follows:

  • Hope S. Rugo, MD (Chair) — UCSF Helen Diller Family Comprehensive Cancer Center
  • Alex A. Adjei, MD — Roswell Park Cancer Institute
  • Johanna Bendell, MD — Sarah Cannon Research Institute, Tennessee Oncology
  • Patrick Borgen, MD — Maimonides Medical Center
  • Julie R. Brahmer, MD — Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
  • Jennifer Brown, MD — Dana Farber Cancer Institute
  • Barbara Burtness, MD — Fox Chase Cancer Center, Temple University
  • Ezra Cohen, MD — UCSD Moores Cancer Center
  • Massimo Cristofanilli, MD — Kimmel Cancer Center, Thomas Jefferson University Hospital
  • Cathy Eng, MD — MD Anderson Cancer Center
  • Alessandra Ferrajoli, MD — MD Anderson Cancer Center
  • Leonard G. Gomella, MD — Kimmel Cancer Center, Thomas Jefferson University Hospital
  • Roy Herbst, MD — Yale Comprehensive Cancer Center
  • Corey Langer, MD — Abramson Cancer Center, University of Pennsylvania
  • Jason Luke, MD — Dana Farber Cancer Institute
  • Maurie Markman, MD — Cancer Treatment Centers of America
  • Susan O’Brien, MD — MD Anderson Cancer Center
  • William Oh, MD — Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute
  • Joyce O’Shaughnessy, MD — Baylor Charles A. Sammons Cancer Center, Texas Oncology
  • Daniel A. Osman, MD — Chair Emeritus, Miami Breast Cancer Conference
  • Roman Perez-Soler, MD — Montefiore Medical Center, Albert Einstein College of Medicine
  • Daniel Petrylak, MD — Yale Comprehensive Cancer Center
  • Lauren C. Pinter-Brown MD — UCLA Geffen School of Medicine
  • Jonathan Strosberg, MD — Moffitt Cancer Center
  • Debu Tripathy, MD — USC Norris Comprehensive Cancer Center
  • Heather Wakelee, MD — Stanford University School of Medicine
  • Jeffrey Weber, MD — Moffitt Cancer Center
  • Howard (Jack) West, MD — Swedish Cancer Institute
  • Andrew Zelenetz, MD — Memorial Sloan-Kettering Cancer Center

“We are proud to welcome our new Advisory Panel members as they help us fulfill our mission to improve the quality of life for cancer patients,” said OncLive Chairman and CEO Mike Hennessy.

The Advisory Panel is chaired by Hope S. Rugo, MD, a medical oncologist and hematologist specializing in breast cancer research and treatment. Rugo is the Director of the Breast Oncology Clinical Trials Program at the UCSF Helen Diller Family Comprehensive Cancer Center, and is the principal investigator for multiple clinical trials focusing on combining novel targeted therapeutics with standard treatment to improve the treatment of both early and late-stage breast cancer. She is an active member of the national cooperative group, CALGB, and is a founding member of the Breast Cancer Research Consortium, as well as serving as an investigator in the UCSF Breast SPORE (the Bay Area Specialized Program of Research Excellence in Breast Cancer). Rugo also teaches medical students and physicians, and regularly lectures locally, nationally and internationally on subjects relating to the treatment of breast cancer.

###

To learn more about the Giants of Cancer Care program and view the 2013 class of Giants, visit giants.onclive.com.About OncLive®

OncLive.com is the official web portal for Intellisphere’s Oncology Specialty Group, which publishes OncologyLive, Oncology & Biotech News, Oncology Nursing News, Urologists in Cancer Care, The American Journal of Hematology/Oncology, and Contemporary Oncology, and presents the Giants of Cancer Care program. The mission of OncLive® and its family of publications is to provide oncology professionals with the resources and information they need to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of healthcare publishing, research, and education. To learn more, please visit www.OncLive.com.

Media Contact:

Mike Gross

For OncLive

267-932-8760 ext. 310

mike@hornercom.com

Related Videos
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Video 1 - "HR+/HER2- Early-Stage Breast Cancer: Background and Risk Stratification "